PMID- 28777258 OWN - NLM STAT- MEDLINE DCOM- 20180502 LR - 20211020 IS - 1473-558X (Electronic) IS - 0959-4965 (Linking) VI - 28 IP - 14 DP - 2017 Sep 27 TI - Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway. PG - 910-916 LID - 10.1097/WNR.0000000000000860 [doi] AB - Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal cell apoptosis. The antisense RNA of brain-derived neurotrophic factor (BDNF-AS) is a natural antisense transcript that is transcribed opposite the gene that encodes BDNF. The aim of this study was to determine whether knockdown of BDNF-AS can suppress hypoxia/reoxygenation (H/R)-induced neuronal cell apoptosis and whether this is mediated by the BDNF-TrkB-PI3K/Akt pathway. We detected the expression of BDNF and BDNF-AS in brain tissue from 20 patients with cerebral infarction and five patients with other diseases (but no cerebral ischemia). We found that BDNF expression was significantly downregulated in patients with cerebral infarction, whereas the expression of BDNF-AS was significantly upregulated. In both human cortical neurons (HCN2) and human astrocytes, H/R significantly induced the expression of BDNF-AS, but significantly decreased BDNF expression. H/R also significantly induced apoptosis and reduced the mitochondrial membrane potential in these cells. Following downregulation of BDNF-AS by siRNA in human cortical neurons and human astrocyte cells, BDNF expression was significantly upregulated and the H/R-induced upregulation of BDNF-AS was significantly attenuated. BDNF-AS siRNA inhibited H/R-induced cell apoptosis and ameliorated the H/R-induced suppression of mitochondrial membrane potential. H/R inhibited the expression of BDNF, p-AKT/AKT, and TrKB, and this inhibition was recovered by BDNF-AS siRNA. In summary, this study indicates that BDNF-AS siRNA induces activation of the BDNF-TrkB-PI3K/Akt pathway following H/R-induced neurotoxicity. These findings will be useful toward the application of BDNF-AS siRNA for the treatment of neurodegenerative diseases. FAU - Zhong, Jian-Bin AU - Zhong JB AD - Department of Neurology, Guangzhuo Zengcheng People's Hospital and Boji Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. FAU - Li, Xie AU - Li X FAU - Zhong, Si-Ming AU - Zhong SM FAU - Liu, Jiu-Di AU - Liu JD FAU - Chen, Chi-Bang AU - Chen CB FAU - Wu, Xiao-Yan AU - Wu XY LA - eng PT - Journal Article PL - England TA - Neuroreport JT - Neuroreport JID - 9100935 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Membrane Glycoproteins) RN - 0 (RNA, Long Noncoding) RN - 0 (RNA, Small Interfering) RN - 7171WSG8A2 (BDNF protein, human) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.10.1 (Receptor, trkB) RN - EC 2.7.10.1 (tropomyosin-related kinase-B, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Apoptosis/*physiology MH - Astrocytes/metabolism/pathology MH - Brain/*metabolism/pathology MH - Brain Ischemia/*metabolism/pathology/therapy MH - Brain-Derived Neurotrophic Factor/antagonists & inhibitors/genetics/*metabolism MH - Cells, Cultured MH - Gene Knockdown Techniques MH - Humans MH - Membrane Glycoproteins/metabolism MH - Membrane Potential, Mitochondrial/physiology MH - Neurons/metabolism/pathology MH - Phosphatidylinositol 3-Kinases/metabolism MH - Proto-Oncogene Proteins c-akt/metabolism MH - RNA, Long Noncoding/antagonists & inhibitors/genetics/*metabolism MH - RNA, Small Interfering MH - Receptor, trkB/metabolism MH - Reperfusion Injury/*metabolism/pathology/therapy MH - Signal Transduction EDAT- 2017/08/05 06:00 MHDA- 2018/05/03 06:00 CRDT- 2017/08/05 06:00 PHST- 2017/08/05 06:00 [pubmed] PHST- 2018/05/03 06:00 [medline] PHST- 2017/08/05 06:00 [entrez] AID - 10.1097/WNR.0000000000000860 [doi] PST - ppublish SO - Neuroreport. 2017 Sep 27;28(14):910-916. doi: 10.1097/WNR.0000000000000860.